Device Trial Radar · NCT07917715
MacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 4, 2026
Primary completion
Aug 16, 2027
Study completion Oct 16, 2027
Sponsor
- Lead sponsor
- Clarity Eye InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- MacuMira
- First posted
- Nov 4, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Age-related macular degeneration (AMD) is an eye condition that affects the retina and can lead to progressive vision loss. This study will evaluate the effects of MacuMira microcurrent stimulation on dark adaptation in adults with intermediate dry AMD. Participants will receive four in-office treatment sessions over 10 to 14 days. Dark adaptation and other measures of visual function and retinal health will be assessed before treatment and at one and three months after treatment.
Conditions
- Age-Related Macular Degeneration (AMD)
Interventions
Transpalpebral microcurrent electrical stimulationDevice
Four in-office sessions of transpalpebral microcurrent electrical stimulation using the MacuMira device. The first treatment session will occur within 7 days of screening/baseline, with the remaining sessions administered over approximately 10 to 14 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Rod Intercept Time (RIT) from Baseline to Month 1Time frame: Average of two baseline assessments (Screening/Baseline and Treatment Day 1) to the single assessment at Month 1.
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Clarity Eye Newmarket
Newmarket, Ontario, Canada
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.